首页> 外文期刊>Journal of digestive diseases >Comparative study of strategies for preventing post‐ERCP pancreatitis after early precut sphincterotomy for biliary access
【24h】

Comparative study of strategies for preventing post‐ERCP pancreatitis after early precut sphincterotomy for biliary access

机译:预防早期预先预先预先介质椎间露立方米胆尘术后策略的比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Objective Needle knife precut sphincterotomy (PS) during endoscopic retrograde cholangiopancreatography (ERCP) has been associated with a high risk of post‐ERCP pancreatitis (PEP). This study aimed to examine the effect of no prophylaxis, somatostatin, rectal diclofenac and pancreatic duct (PD) stenting in reducing rates of PEP in patients who underwent early PS. Methods This was a retrospective comparative study and the study period was from January 2006 to December 2015. A standardized approach to early PS was used: (i) inadvertent guidewire cannulation of the PD??thrice; (ii) impacted bile duct stone; (iii) inability to achieve deep cannulation within 10?min. PEP prophylactic measures included: (i) none when there was minimal papilla trauma; (ii) somatostatin infusion; (iii) rectal diclofenac; (iv) PD stent. The difference in rates of PEP between the different strategies was analysed. Results During the study period, PS was performed in 191 ERCP patients (mean age 66?years; 56.5% males). The ERCP success rate after PS was 93.2% (178/191). Overall the PEP rate was 3.1% (6/191) and the severity in all cases was mild. PEP occurred in 6.1% of patients with PD cannulation but not in those without ( P = 0.016). PEP rates were 1.8%, 7.3%, 1.8% and 0% in control, somatostatin, diclofenac and PD stenting groups, respectively ( P = 0.209). Conclusions There was no significant difference in PEP rates after early PS whether or not prophylactic measures were adopted if there was minimal papilla trauma. A trend towards lower PEP rates was observed in patients who had either rectal diclofenac or PD stenting, compared to somatostatin.
机译:摘要目的针刀预先晶体切除术(PS)在内窥镜逆行胆管胰岛素(ERCP)中已与ERCP后胰腺炎(PEP)的高风险有关。本研究旨在检测任何预防,生长抑制素,直肠双氯芬酸和胰腺导管(PD)在接受早期PS患者的PEP率方面的效果。方法这是回顾性比较研究,研究期为2006年1月至2015年12月。使用了对PS的标准化方法:(i)无意导游PD导丝加固&? (ii)受影响的胆管石; (iii)无法在10?min内实现深度插管。 PEP预防性措施包括:(i)当乳头创伤最小时无; (ii)生长抑制素输注; (iii)直肠直裂; (iv)PD支架。分析了不同策略之间的PEP率的差异。结果在研究期间,PS在191名ERCP患者中进行(平均年龄66岁)。 PS后的ERCP成功率为93.2%(178/191)。总体而言,PEP率为3.1%(6/191),所有病例的严重程度都很轻盈。 PEP发生在6.1%的PD插管患者中,但不含(P = 0.016)。 PEP,SOMatostatin,双氯芬酸和Pd支架组的PEP率分别为1.8%,7.3%,1.8%和0%(P = 0.209)。结论如果乳头创伤最小,则在PS期间是否采用预防性措​​施,PES无论是否采用预防性措​​施就没有显着差异。与生长抑素相比,在具有直肠二氯芬酸或PD支架的患者中观察到降低PEP率的趋势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号